Transplantation for Hepatocellular Carcinoma and Cholangiocarcinoma

View More View Less
  • 1 Division of Transplantation, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska
  • 2 Journal of the National Comprehensive Cancer Network
Restricted access

Hepatocellular carcinoma (HCC) and cholangiocarcinoma represent more than 95% of primary hepatic malignancies in adults. The incidence of both seems to be rising. Any form of cirrhosis and primary sclerosing cholangitis represent independent risk factors for the development of HCC and cholangiocarcinoma, respectively. The surgical treatment of these malignancies has evolved significantly in the past decade, and liver transplantation (LT) has revolutionized the prognosis of these conditions. Provided both malignancies are diagnosed early in their natural history, LT offers a greater than 75% chance of survival at 4 years. This is a remarkable improvement in the treatment of primary hepatic malignancies and compares favorably with any other form of treatment, including partial liver resection. The application of specific pretransplantation staging criteria, along with the addition of neoadjuvant chemoradiation therapy for cholangiocarcinoma, has made these results possible. The development of living donor LT further expands the treatment horizon for both diseases. It also lessens the impact of the scarcity of available deceased donor organs available for transplantation. The future challenge is to better characterize biologic staging/prognostic indicators that could expand the understanding and success in treating both malignancies.

Correspondence: B. Daniel Campos, MD, Division of Transplantation, Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198. E-mail: danielcampos@mac.com

Disclosure: B. Daniel Campos, MD, has disclosed no relevant financial relationships.

Disclosure: Jean F. Botha, MD, has disclosed no relevant financial relationships.

Disclosure: Kerrin G. Robinson, MA, has disclosed no relevant financial relationships.

  • 1

    Bosch FX, Ribes JM, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127(5 Suppl 1):S516.

  • 2

    Ryder S. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52(Suppl III):iii1iii8.

  • 3

    Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:19071917.

  • 4

    Blum HE, Spangenberg HC. Hepatocellular carcinoma: an update. Arch Iran Med 2007;10:361371.

  • 5

    Detry O. Highlights of the 9th Meeting of the International Liver Transplantation Society (ILTS) and the 13th Meeting of the Liver Intensive Care Group of Europe (LICAGE) [Medscape CME Web site]. Available at: http://cme.medscape.com/viewarticle/458150_1. Accessed January 30, 2009.

    • Search Google Scholar
    • Export Citation
  • 6

    Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;2:270285.

    • Search Google Scholar
    • Export Citation
  • 7

    Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Eng J Med 1996;334:693699.

    • Search Google Scholar
    • Export Citation
  • 8

    Jonas S, Bechstein WO, Steinmuller T. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;5:10801086.

    • Search Google Scholar
    • Export Citation
  • 9

    Bruix J, Fuster J, Llovet JM. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003;7:700702.

    • Search Google Scholar
    • Export Citation
  • 10

    Wiesner R, Edwards E, Freeman R. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:9196.

  • 11

    Kamath PS, Wiesner RH, Malinchoc M. A model to predict survival in patients with end stage liver disease. Hepatology 2001;33:464470.

  • 12

    Llovet JM, Bruix J, Fuster J. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:15721577.

    • Search Google Scholar
    • Export Citation
  • 13

    Yao FY, Ferrell L, Bass NM. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:13941403.

    • Search Google Scholar
    • Export Citation
  • 14

    Decaens T, Roudot-Thoraval F, Hadni-Bresson S. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006;12:17611769.

    • Search Google Scholar
    • Export Citation
  • 15

    Leung JY, Zhu AX, Gordon FD. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004;11:13431354.

    • Search Google Scholar
    • Export Citation
  • 16

    Onaca N, Davis GL, Goldstein RM. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007;13:391399.

    • Search Google Scholar
    • Export Citation
  • 17

    Sotiropoulos GC, Molmenti EP, Omar OS. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria. Eur J Med Res 2006;11:467470.

    • Search Google Scholar
    • Export Citation
  • 18

    Duffy JP, Vardanian A, Benjamin E. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502509; discussion 509–511.

    • Search Google Scholar
    • Export Citation
  • 19

    Majno PE, Adam R, Bismuth H. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688701.

    • Search Google Scholar
    • Export Citation
  • 20

    Graziadei IW, Sandmueller H, Waldenberger P. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003;9:557563.

    • Search Google Scholar
    • Export Citation
  • 21

    Mazzaferro V, Battiston C, Perrone S. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900909.

    • Search Google Scholar
    • Export Citation
  • 22

    Lesurtel M, Müllhaupt B, Pestalozzi BC. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 2006;6:26442650.

    • Search Google Scholar
    • Export Citation
  • 23

    Freeman RB Jr, Steffick DE, Guidinger MK. Liver and intestine transplantation in the United States, 1997–2006. Am J Transplant 2008;8(4 Pt 2):958976.

    • Search Google Scholar
    • Export Citation
  • 24

    Freeman RB Jr. Transplantation for hepatocellular carcinoma: the Milan criteria and beyond. Liver Transpl 2006;12(11 Suppl 2):S813

  • 25

    Yao FY, Kerlan RK Jr, Hirose R. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008;48:819827.

    • Search Google Scholar
    • Export Citation
  • 26

    Otto G, Herber S, Heise M. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006;12:12601267.

    • Search Google Scholar
    • Export Citation
  • 27

    Adam R, Azoulay D, Castaing D. Liver resection as a bridge to transplantation for hepatocellular carcinomaon cirrhoisi: a reasonable strategy? Ann Surg 2004;238:508518.

    • Search Google Scholar
    • Export Citation
  • 28

    Del Gaudio M, Ercolani G, Ravaioli M. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008;8:11771185.

    • Search Google Scholar
    • Export Citation
  • 29

    Botha JF, Campos BD. Salvage transplantation: does saving livers save lives? Am J Transplant 2008;8:10851086.

  • 30

    Qin JM, Takada Y, Uemoto S, Tanaka K. Present status and recent advances in living donor liver transplantation for malignant hepatic tumors. Hepatobiliary Pancreat Dis Int 2008;7:126134.

    • Search Google Scholar
    • Export Citation
  • 31

    Poon RT, Fan ST, Lo CM. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373382.

    • Search Google Scholar
    • Export Citation
  • 32

    Fisher RA, Kulik LM, Freise CE. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007;7:16011608.

    • Search Google Scholar
    • Export Citation
  • 33

    Lo CM, Fan ST, Liu CL. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007;94:7886.

    • Search Google Scholar
    • Export Citation
  • 34

    Umeshita K, Fujiwara K, Kiyosawa K. Operative morbidity of living liver donors in Japan. Lancet 2003;362:687690.

  • 35

    Ringe B, Pichlmayr R, Wittekind C. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270285.

    • Search Google Scholar
    • Export Citation
  • 36

    Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998;228:479490.

    • Search Google Scholar
    • Export Citation
  • 37

    Iwatsuki S, Starzl TE, Sheahan DG. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221228.

  • 38

    Mazzaferro V, Chun YS, Poon RT. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008;15:10011007.

  • 39

    Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975;140:170178.

    • Search Google Scholar
    • Export Citation
  • 40

    Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:3138.

  • 41

    Kosuge T, Yamamoto J, Shimada K. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999;230:663671.

    • Search Google Scholar
    • Export Citation
  • 42

    Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 2001;234:270276.

  • 43

    Jarnagin WR, Fong Y, DeMatteo RP. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507517.

    • Search Google Scholar
    • Export Citation
  • 44

    Bismuth H, Castaing D, Ericzon BG. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet 1987;2:674676.

    • Search Google Scholar
    • Export Citation
  • 45

    Iwatsuki S, Todo S, Marsh JW. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358364.

    • Search Google Scholar
    • Export Citation
  • 46

    O’Grady JG, Polson RJ, Rolles K. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373379.

    • Search Google Scholar
    • Export Citation
  • 47

    Neuhaus P, Jonas S, Bechstein WO. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808819.

  • 48

    Sudan D, DeRoover A, Chinnakotla S. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002;2:774779.

    • Search Google Scholar
    • Export Citation
  • 49

    Rea DJ, Heimbach JK, Rosen CB. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451461.

    • Search Google Scholar
    • Export Citation
  • 50

    De Vreede I, Steers JL, Burch PA. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309316.

    • Search Google Scholar
    • Export Citation
  • 51

    Neuhaus P, Jonas S, Settmacher U. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg 2003;388:194200.

    • Search Google Scholar
    • Export Citation
  • 52

    Mantel HT, Rosen CB, Heimbach JK. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007;13:13721381.

    • Search Google Scholar
    • Export Citation
  • 53

    Heimbach JK, Gores GJ, Haddock MG. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006;27;82:17031707.

    • Search Google Scholar
    • Export Citation
  • 54

    Gores GJ, Gish RG, Sudan D. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 2006;12:S9597.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 67 52 3
PDF Downloads 19 17 0
EPUB Downloads 0 0 0